WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues.

India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...

Review which funds and institutions currently hold Sun Pharmaceuticals Industries Ltd (SUNPHARMA:XNSE) stock for ownership information.

Sun Pharma’s most recent acquisition (completed in May 2023) was that of US-based Concert Pharmaceuticals for $576 million, which is aimed at accessing Concert’s experimental drug ...

Our faculty is renowned in their fields and distinguished by their excellence in teaching, research, and creative activity. Use this searchable directory to find faculty by name, school, other key ...